New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
Le Lézard,
Masimo (NASDAQ: MASI) today announced the findings of a study published in Frontiers in Neuroscience in which Dr.